Aarvik Therapeutics
Aarvik Therapeutics is a startup headquartered in Hayward, United States, founded in 2020. It has raised at least $1.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Aarvik Therapeutics has raised at least $1.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Aarvik Therapeutics sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in Hayward
Related
- Innovation profile of Hayward
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Aarvik Therapeutics do?
Aarvik Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Aarvik Therapeutics raised?
At least $1.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Aarvik Therapeutics based?
Aarvik Therapeutics is headquartered in Hayward, United States.
When was Aarvik Therapeutics founded?
Aarvik Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.